Jayne Gershkowitz, SVP, Chief Patient Advocate at AMICUS THERAPEUTICS INC (FOLD), sold 19,307 shares at $10.84 ($209K) on 2015-05-11, disclosed to the SEC on 2015-05-12.
Scheduled sale ($209k) by SVP, Chief Patient Advocate under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.80 | 9,307 | $101K | 48.1% |
| 2 | $10.84 | 10,000 | $108K | 51.9% |
| Total | $10.82 avg | 19,307 | $209K | 100% |
| Filing → |
| FOLD | SELL | 2014-08-29 | $35K | — | Filing → |
| FOLD | BUY | 2014-08-29 | $35K | — | Filing → |
| FOLD | SELL | 2014-08-26 | $30K | — | Filing → |